In conclusion, our findings demonstrate that sorafenib enhances the secretion of IFN-γ and TNF-α by CD8 + T cells, thereby activating their cytotoxic function and inhibiting the invasion and survival of CESC cells. Here, CD8A is linked to cervical squamous cell carcinoma.